{
  "LinkTitle": "D-2021-1217",
  "Status": "Initial",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "FWO",
  "ProjectTitle": "Chemokine receptor CXCR3 and its ligands: activity regulation and role in autoinflammatory diseases and juvenile idiopathic arthritis",
  "InitialFeedbackHistory": "04/05/2022 2. Please note that, in addition to digital files, physical samples are also considered data 3. [REDACTED] privacy registry reference is your PRET approval number that you now mention under ethics 4. [REDACTED] the second subquestion you can refer to the metadata that you describe in the first subquestion. [REDACTED] a metadata standard collection that may be useful for your work is the MIBBI (https://fairsharing.org/3518) for example MIFlowCyt (https://fairsharing.org/FAIRsharing.kcnjj2). [REDACTED] you like to discuss this in more detail please contact onderzoek2bergen@kuleuven.be 5. [REDACTED] mention many different storage solutions, how do you decide where which data is stored? [REDACTED] sure personal data is stored conform you PRET application. 6. Please note that the KU [REDACTED] RDM policy expects relevant data to be preserved for 10 years. [REDACTED] you collect any data that is part of a clinical trail the UZL CTC expects these to be preserved for 25 years, see https://gbiomed.kuleuven.be/english/ctc for more information. [REDACTED] note that onedrive is linked the researcher's account and will expire when the owner leaves KU [REDACTED] and is therefore not suitable for long term data preservation 7. [REDACTED] can also mention privacy as factor restricting sharing. [REDACTED] data sharing (under open or restricted access) you can also consider to use KU [REDACTED] RDR (https://www.kuleuven.be/rdm/en/rdr)",
  "label": "good with suggestions"
}